Cancer and ageing
Human evidence and active trials are visible in this field
515 human-evidence records · 160 active trials · 560 visible funding records · 6,594 universities
Longevity Patent Family
PROTEIN NANOPARTICLES TO INCREASE EXERCISE ENDURANCE, FUNCTIONALITY AND LONGEVITY IN CANCER AND NON-CANCER PATIENTS
Source-linked patent metadata for PROTEIN NANOPARTICLES TO INCREASE EXERCISE ENDURANCE, FUNCTIONALITY AND LONGEVITY IN CANCER AND NON-CANCER PATIENTS, including priority, record stage and longevity-topic connections.
Patent-family snapshot
Application publication visible
Family grouping brings related publications for the same invention together, instead of counting every national filing as a separate technology.
- Representative publication
- US20260240787A1
- Earliest priority
- March 22, 2021
- Latest publication
- August 20, 2026
- Family publications
- 1
- Patent offices
- 1
Patent-to-Evidence Translation Map
What is happening in the same scientific field?
These connections share a longevity topic with this patent record. They do not prove that the listed evidence, trials, funders, or universities validate, finance, own, or support this invention.
Exercise
Human evidence and active trials are visible in this field
2,539 human-evidence records · 204 active trials · 256 visible funding records · 6,160 universities
Organizations named in this family
Topics connected by metadata
Cancer and ageing88% metadata match
Exercise88% metadata match
What this family cites
- Earlier patent references
- 0
- Scientific and other non-patent references
- 0
- Priority dates represented
- 7
References show which earlier documents the patent record points to. They do not validate the invention or prove that cited research supports its claims.
How the patent office classifies this invention
No patent classification is available in the retained record.
Verify in the original patent source →